Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of "Truth": Content, Face and Construct Validity

P. Tugwell; M. Boers; M.A. D'Agostino; D. Beaton; A. Boonen; C.O. Bingham III; E. Choy; P.G. Conaghan; M. Dougados; C. Duarte; D.E. Furst; F. Guillemin; L. Gossec; T. Heiberg; D.M. van der Heijde; S. Hewlett; J.R. Kirwan; T.K. Kvien; R.B. Landewé; P.J. Mease; M. Ostergaard; L. Simon; J.A. Singh; V. Strand; G. Wells

doi:10.3899/jrheum.131310

Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of "Truth": Content, Face and Construct Validity

P. Tugwell^*, M. Boers, M.A. D'Agostino, D. Beaton, A. Boonen, C.O. Bingham III, E. Choy, P.G. Conaghan, M. Dougados, C. Duarte, D.E. Furst, F. Guillemin, L. Gossec, T. Heiberg, D.M. van der Heijde, S. Hewlett, J.R. Kirwan, T.K. Kvien, R.B. Landewé, P.J. MeaseM. Ostergaard, L. Simon, J.A. Singh, V. Strand, G. Wells

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity.

Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved.

Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address.

Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.

Original language	English
Pages (from-to)	1000-1004
Number of pages	5
Journal	Journal of Rheumatology
Volume	41
Issue number	5
DOIs	https://doi.org/10.3899/jrheum.131310
Publication status	Published - May 2014

Keywords

OMERACT
RANDOMIZED CONTROLLED TRIALS
OUTCOME AND PROCESS ASSESSMENT
CONSTRUCT VALIDITY
CONTENT VALIDITY
FACE VALIDITY

Access to Document

10.3899/jrheum.131310

Cite this

Tugwell, P., Boers, M., D'Agostino, M. A., Beaton, D., Boonen, A., Bingham III, C. O., Choy, E., Conaghan, P. G., Dougados, M., Duarte, C., Furst, D. E., Guillemin, F., Gossec, L., Heiberg, T., van der Heijde, D. M., Hewlett, S., Kirwan, J. R., Kvien, T. K., Landewé, R. B., ... Wells, G. (2014). Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of "Truth": Content, Face and Construct Validity. Journal of Rheumatology, 41(5), 1000-1004. https://doi.org/10.3899/jrheum.131310

@article{6a4c2209a28d4dfab359097613726d19,

title = "Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of {"}Truth{"}: Content, Face and Construct Validity",

abstract = "Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The {"}Truth{"} section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity.Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved.Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address.Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.",

keywords = "OMERACT, RANDOMIZED CONTROLLED TRIALS, OUTCOME AND PROCESS ASSESSMENT, CONSTRUCT VALIDITY, CONTENT VALIDITY, FACE VALIDITY",

author = "P. Tugwell and M. Boers and M.A. D'Agostino and D. Beaton and A. Boonen and {Bingham III}, C.O. and E. Choy and P.G. Conaghan and M. Dougados and C. Duarte and D.E. Furst and F. Guillemin and L. Gossec and T. Heiberg and {van der Heijde}, D.M. and S. Hewlett and J.R. Kirwan and T.K. Kvien and R.B. Landew{\'e} and P.J. Mease and M. Ostergaard and L. Simon and J.A. Singh and V. Strand and G. Wells",

year = "2014",

month = may,

doi = "10.3899/jrheum.131310",

language = "English",

volume = "41",

pages = "1000--1004",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology Publishing Co. Ltd.",

number = "5",

}

Tugwell, P, Boers, M, D'Agostino, MA, Beaton, D, Boonen, A, Bingham III, CO, Choy, E, Conaghan, PG, Dougados, M, Duarte, C, Furst, DE, Guillemin, F, Gossec, L, Heiberg, T, van der Heijde, DM, Hewlett, S, Kirwan, JR, Kvien, TK, Landewé, RB, Mease, PJ, Ostergaard, M, Simon, L, Singh, JA, Strand, V & Wells, G 2014, 'Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of "Truth": Content, Face and Construct Validity', Journal of Rheumatology, vol. 41, no. 5, pp. 1000-1004. https://doi.org/10.3899/jrheum.131310

TY - JOUR

T1 - Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of "Truth": Content, Face and Construct Validity

AU - Tugwell, P.

AU - Boers, M.

AU - D'Agostino, M.A.

AU - Beaton, D.

AU - Boonen, A.

AU - Bingham III, C.O.

AU - Choy, E.

AU - Conaghan, P.G.

AU - Dougados, M.

AU - Duarte, C.

AU - Furst, D.E.

AU - Guillemin, F.

AU - Gossec, L.

AU - Heiberg, T.

AU - van der Heijde, D.M.

AU - Hewlett, S.

AU - Kirwan, J.R.

AU - Kvien, T.K.

AU - Landewé, R.B.

AU - Mease, P.J.

AU - Ostergaard, M.

AU - Simon, L.

AU - Singh, J.A.

AU - Strand, V.

AU - Wells, G.

PY - 2014/5

Y1 - 2014/5

N2 - Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity.Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved.Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address.Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.

AB - Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity.Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved.Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address.Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.

KW - OMERACT

KW - RANDOMIZED CONTROLLED TRIALS

KW - OUTCOME AND PROCESS ASSESSMENT

KW - CONSTRUCT VALIDITY

KW - CONTENT VALIDITY

KW - FACE VALIDITY

U2 - 10.3899/jrheum.131310

DO - 10.3899/jrheum.131310

M3 - Article

C2 - 24692531

SN - 0315-162X

VL - 41

SP - 1000

EP - 1004

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 5

ER -